TriLink BioTechnologies, Inc. Announces License Agreement with LI-COR Biosciences

"This offers our customers a product option that will be more specific to their research, while being based on the IRDye near-infrared dye technology they have grown to trust," says Jim Wiley, LI-COR senior strategic marketing manager. "TriLink has established itself as an expert in the field of modified nucleic acids and we're certain our customers will benefit from this agreement."

LI-COR offers IRDye near-infrared dye technology that delivers enhanced sensitivity due to low background autofluorescence in the near-infrared region and, therefore, higher signal to noise ratios. IRDye near-infrared dyes have absorption and emission wavelengths in the near-infrared spectrum, between 650 nm and 800 nm.

"As experts in modified nucleic acid chemistry and leaders in dye labeling nucleoside triphosphates and oligonucleotides, we are continually expanding our portfolio of available modifications," says Richard Hogrefe, Ph.D., TriLink president and CEO. "The innovative LI-COR infrared dye series, IRDye 650-800, is a perfect fit, opening new doors for our customers seeking enhanced signal-to-noise ratios and dynamic range in applications where autofluorescence is an issue."